FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012127625> ?p ?o ?g. }

• W2012127625 endingPage "2433" @default.
• W2012127625 startingPage "2427" @default.
• W2012127625 abstract "Abstract The active form of vitamin D3, 1,25(OH)2D3, inhibits proliferation and induces differentiation of a variety of malignant cells. A new class of vitamin D3 analogs, having 2 identical side chains attached to carbon-20, was synthesized and the anticancer effects evaluated. Four analogs were evaluated for their ability to inhibit growth of myeloid leukemia (NB4, HL-60), breast (MCF-7), and prostate (LNCaP) cancer cells. All 4 analogs inhibited growth in a dose-dependent manner. Most effective was 21-(3-methyl-3-hydroxy-butyl)-19-nor D3(Gemini-19-nor), which has 2 side chains and removal of the C-19. Gemini-19-nor was approximately 40 625-, 70-, 23-, and 380-fold more potent than 1,25(OH)2D3 in inhibiting 50% clonal growth (ED50) of NB4, HL-60, MCF-7, and LNCaP cells, respectively. Gemini-19-nor (10−8 M) strongly induced expression of CD11b and CD14 on HL-60 cells (90%); in contrast, 1,25(OH)2D3 (10−8 M) stimulated only 50% expression. Annexin V assay showed that Gemini-19-nor and 1,25(OH)2D3 induced apoptosis in a dose-dependent fashion. Gemini-19-nor (10−8 M, 4 days) caused apoptosis in approximately 20% of cells, whereas 1,25(OH)2D3 at the same concentration did not induce apoptosis. Gemini-19-nor increased in HL-60 both the proportion of cells in the G1/G0 phase and expression level of p27kip1. Moreover, Gemini-19-nor stimulated expression of the potential tumor suppressor, PTEN. Furthermore, other inducers of differentiation, all-trans-retinoic acid and 12-O-tetradecanoylphorbol 13-acetate, increased PTEN expression in HL-60. In summary, Gemini-19-nor strongly inhibited clonal proliferation in various types of cancer cells, especially NB4 cells, suggesting that further studies to explore its anticancer potential are warranted. In addition, PTEN expression appears to parallel terminal differentiation of myeloid cells." @default.
• W2012127625 created "2016-06-24" @default.
• W2012127625 creator A5034479183 @default.
• W2012127625 creator A5039109076 @default.
• W2012127625 creator A5082903377 @default.
• W2012127625 creator A5082910041 @default.
• W2012127625 creator A5090964107 @default.
• W2012127625 date "2001-04-15" @default.
• W2012127625 modified "2023-09-28" @default.
• W2012127625 title "Novel vitamin D3 analog, 21-(3-methyl-3-hydroxy-butyl)-19-nor D3, that modulates cell growth, differentiation, apoptosis, cell cycle, and induction of PTEN in leukemic cells" @default.
• W2012127625 cites W1489145507 @default.
• W2012127625 cites W161022802 @default.
• W2012127625 cites W1969688760 @default.
• W2012127625 cites W1973577899 @default.
• W2012127625 cites W1974102418 @default.
• W2012127625 cites W1981201843 @default.
• W2012127625 cites W1984418041 @default.
• W2012127625 cites W1995022492 @default.
• W2012127625 cites W2000079492 @default.
• W2012127625 cites W2009640214 @default.
• W2012127625 cites W2017191360 @default.
• W2012127625 cites W2024220711 @default.
• W2012127625 cites W2038577241 @default.
• W2012127625 cites W2039671291 @default.
• W2012127625 cites W2043650909 @default.
• W2012127625 cites W2046701443 @default.
• W2012127625 cites W2048162018 @default.
• W2012127625 cites W2068345721 @default.
• W2012127625 cites W2070942270 @default.
• W2012127625 cites W2071429904 @default.
• W2012127625 cites W2078209674 @default.
• W2012127625 cites W2080569014 @default.
• W2012127625 cites W2094523739 @default.
• W2012127625 cites W2111125738 @default.
• W2012127625 cites W2118275179 @default.
• W2012127625 cites W2130867126 @default.
• W2012127625 cites W2147114673 @default.
• W2012127625 cites W2157023326 @default.
• W2012127625 cites W2161810908 @default.
• W2012127625 cites W2416433152 @default.
• W2012127625 cites W248352688 @default.
• W2012127625 cites W4324293773 @default.
• W2012127625 cites W69869516 @default.
• W2012127625 doi "https://doi.org/10.1182/blood.v97.8.2427" @default.
• W2012127625 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11290607" @default.
• W2012127625 hasPublicationYear "2001" @default.
• W2012127625 type Work @default.
• W2012127625 sameAs 2012127625 @default.
• W2012127625 citedByCount "74" @default.
• W2012127625 countsByYear W20121276252012 @default.
• W2012127625 countsByYear W20121276252013 @default.
• W2012127625 countsByYear W20121276252014 @default.
• W2012127625 countsByYear W20121276252015 @default.
• W2012127625 countsByYear W20121276252017 @default.
• W2012127625 countsByYear W20121276252018 @default.
• W2012127625 countsByYear W20121276252019 @default.
• W2012127625 countsByYear W20121276252022 @default.
• W2012127625 crossrefType "journal-article" @default.
• W2012127625 hasAuthorship W2012127625A5034479183 @default.
• W2012127625 hasAuthorship W2012127625A5039109076 @default.
• W2012127625 hasAuthorship W2012127625A5082903377 @default.
• W2012127625 hasAuthorship W2012127625A5082910041 @default.
• W2012127625 hasAuthorship W2012127625A5090964107 @default.
• W2012127625 hasBestOaLocation W20121276251 @default.
• W2012127625 hasConcept C121608353 @default.
• W2012127625 hasConcept C126322002 @default.
• W2012127625 hasConcept C134018914 @default.
• W2012127625 hasConcept C153911025 @default.
• W2012127625 hasConcept C185592680 @default.
• W2012127625 hasConcept C190283241 @default.
• W2012127625 hasConcept C2778461978 @default.
• W2012127625 hasConcept C2779707156 @default.
• W2012127625 hasConcept C2779723316 @default.
• W2012127625 hasConcept C29537977 @default.
• W2012127625 hasConcept C502942594 @default.
• W2012127625 hasConcept C55493867 @default.
• W2012127625 hasConcept C62112901 @default.
• W2012127625 hasConcept C71924100 @default.
• W2012127625 hasConcept C86803240 @default.
• W2012127625 hasConcept C96232424 @default.
• W2012127625 hasConceptScore W2012127625C121608353 @default.
• W2012127625 hasConceptScore W2012127625C126322002 @default.
• W2012127625 hasConceptScore W2012127625C134018914 @default.
• W2012127625 hasConceptScore W2012127625C153911025 @default.
• W2012127625 hasConceptScore W2012127625C185592680 @default.
• W2012127625 hasConceptScore W2012127625C190283241 @default.
• W2012127625 hasConceptScore W2012127625C2778461978 @default.
• W2012127625 hasConceptScore W2012127625C2779707156 @default.
• W2012127625 hasConceptScore W2012127625C2779723316 @default.
• W2012127625 hasConceptScore W2012127625C29537977 @default.
• W2012127625 hasConceptScore W2012127625C502942594 @default.
• W2012127625 hasConceptScore W2012127625C55493867 @default.
• W2012127625 hasConceptScore W2012127625C62112901 @default.
• W2012127625 hasConceptScore W2012127625C71924100 @default.
• W2012127625 hasConceptScore W2012127625C86803240 @default.
• W2012127625 hasConceptScore W2012127625C96232424 @default.
• W2012127625 hasIssue "8" @default.
• W2012127625 hasLocation W20121276251 @default.

• next